Pharmacyte Biotech Inc. buy Sievi
Start price
25.08.21
/
50%
€3.05
Target price
25.08.22
-
Performance (%)
-8.85%
End price
14.09.21
€2.78
Summary
This prediction ended on 14.09.21 with a price of €2.78. With a performance of -8.85%, the BUY prediction for Pharmacyte Biotech Inc. by Sievi closed slightly in the red. Sievi has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pharmacyte Biotech Inc. | - | - | - |
| iShares Core DAX® | 2.594% | -1.861% | 13.242% |
| iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% |
| iShares Nikkei 225® | 0.687% | -8.704% | 17.510% |
| iShares S&P 500 | 2.209% | -1.988% | 27.632% |
According to Sievi what are the pros and cons of Pharmacyte Biotech Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
